Abiopharma

Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa

Ensysce Biosciences Receives EU Patent Expanding its First-in-Class ADHD Therapy with Built-In Abuse and Overdose Protection

Reviva Announces Publication on Clinical Vocal Biomarker Data from the RECOVER Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia

CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates

XWELL Reaffirms Commitment to Biosecurity, Appoints Former CDC Senior Advisor

Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications

Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference

Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications

New Form SCHEDULE 13G - JOINT Corp Filed: 2026-01-08 AccNo: 0001821268-26-000003 Size: 6 KB

Curaleaf Announces Proposed Domestication to Delaware

(90% Positive) Context Therapeutics Inc. (CNTX) Provides Update on reflected for such are reasonable

New Form ARS - Modular Medical, Inc. Filed: 2026-01-08 AccNo: 0001213900-26-002333 Size: 731 KB

New Form DEF 14A - Modular Medical, Inc. Filed: 2026-01-08 AccNo: 0001213900-26-002332 Size: 22 MB

GH Research PLC (GHRS) Files Form 6-K

Vera Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference